Articles

Find an Article

Filter articles

Showing 231 to 240 of 737 results

LSIPR 50 2017: Lars Kellberg—The challenge of IPRs

US10-11-2017

In the current IP landscape it is wise to be prepared for attacks on important patents, as Lars Kellberg, corporate vice president and corporate patents of Novo Nordisk, explains to LSIPR.

LSIPR 50 2017: Stéphane Drouin—Innovation in a volatile climate

Belgium10-11-2017

Pharmaceutical company UCB injects a significant amount of revenue into R&D, but it is mindful of the risks attached to drug investment. Global head of IP Stéphane Drouin explains more in an interview with LSIPR.

LSIPR 50 2017: Larry Coury—The art of successful litigation

US10-11-2017

Resolving complex legal disputes and explaining technical concepts in a courtroom are all part of the job for Regeneron’s Larry Coury, who talks to LSIPR about life as senior director of dispute resolution.

LSIPR 50 2017: Richard Henderson—Meet the hands-on scientist

UK10-11-2017

Richard Henderson, an award-winning scientist based in Cambridge, UK, is seeking to make his next important discovery in the field of biological electron microscopy, as LSIPR finds out.

LSIPR 50 2017: Audrey Goddard—Science is for girls too

US10-11-2017

A prolific patentee, Audrey Goddard believes women should be patenting more inventions in the STEM industries. She explains more to LSIPR.

LSIPR 50 2017: Anthony Atala—Surgeon by day, researcher by night

US10-11-2017

Anthony Atala combines the roles of surgeon and researcher in regenerative medicine, allowing him to stay mindful of why his work is important. He talks to LSIPR about his twin professions.

LSIPR 50: Daniela Verthelyi—Safety first

US10-11-2017

Finding therapies that are safe, effective and available requires hard work and putting patients first, according to Daniela Verthelyi of the FDA, who discusses her role as chief of the immunology laboratory at the government agency.

LSIPR 50 2017: Sean Dennehey—Steering the ship

UK10-11-2017

From the Unified Patent Court to life sciences industrial strategy, there are many issues for Sean Dennehey to contend with as deputy CEO of the UK Intellectual Property Office. He talks to LSIPR about how he managed.

LSIPR 50 2017: Steve Bates—Dreaming big for UK bioscience

UK10-11-2017

As CEO of the UK BioIndustry Association, Steve Bates works closely with industry and government and, by 2025, he wants the UK to become home to the third biggest global biotech cluster, as he explains to LSIPR.

LSIPR 50 2017: Jennifer Doudna

US10-11-2017

Jennifer Doudna was selected in the LSIPR 50 2017 publication for her influence on the life sciences industry. She featured in the business and innovation section, as LSIPR reports.

Showing 231 to 240 of 737 results

LSIPR